The Role of Professonal Socieites in Improving Mental Healthcare in Minnesota

Steven Giradeau, PsyD, LP

Joel Oberstar, MD

Introduction

Dr. Steven Girardeau has a doctorate in Counseling Psychology and is a Licensed Psychologist.  He is the 2017 Minnesota Psychological Association (MPA) President as well as the certification chair of the Dialectical Behavior Therapy National Certification and Accreditation Association (DBTNCAA) and the director of clinical services for MHS, one of the largest DBT-specialized practices in the Midwest.  He has overseen the care of thousands of clients with co-morbid major mental health and personality disorders in an intensive outpatient setting.  Dr. Girardeau has been a therapist for over two decades, specializing in providing clinical services to clients with serious and persistent mental health diagnoses as well as chemical use disorders.  He has worked as a clinician, clinical director, training director, program supervisor and a clinical team consultant.  He has provided trainings at national/state/regional/local events and created training programs in the areas of DBT, abuse, safety planning and treatment of clients with dual disorders.

Dr. Joel Oberstar is PrairieCare’s CEO and a Child and Adolescent Psychiatrist seeing outpatients in Brooklyn Park. Dr. Oberstar is Board Certified in Psychiatry, Child & Adolescent Psychiatry and Addiction Medicine and is Adjunct Assistant Professor of Psychiatry at the University of Minnesota Medical School.  He is just completed a one-year term as President of the Minnesota Psychiatric Society.

Learning Objectives

1. Describe the mission, vision and values articulated by the Minnesota Psychiatric Society and the Minnesota Psychological Association.
2. Describe the recent activities of each organization over the past year.
3. Describe the organizations' plans for the coming year.

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements
• Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.
• Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science (Mayo Clinic School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 

Speaker Joel Oberstar, MD: 

Stock Shareholder:  PrairieCare; PrairieCare Medical Group; Paragon Residential Treatment for Youth LLC; Catch LLC

Full-time/Employee:  Employee of PrairieCare Medical Group; CEO of PrairieCare

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, RN, M.S., Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Charlene Nelson

Speaker:  Steven Girardeau, PsyD, LP

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  NONE